Level Bio AB (publ) (NGM: LEVBIO)
Health Care · Life Sciences Tools & Services · SE
Skr0.32
+21.54% today · -4.2% 1Y
Level Bio AB (publ) (NGM: LEVBIO) operates in the Life Sciences Tools & Services industry within the Health Care sector. The company is valued at $2.28M.
Over the last twelve months the share price has lost 4.2%, trading between 0.23 and 0.45.
Tweenvest scores Level Bio AB (publ) across four factors: quality 55/100, value 67/100, growth 0/100. Its strongest factor is value.
LEVBIO price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $2.28M
- Revenue (TTM)
- $3.55M
- P/E
- —
- EPS
- —
- Dividend yield
- —
- Beta (5Y)
- 1.29
- 52-week high
- Skr0.45
- 52-week low
- Skr0.23
- Avg volume (3M)
- —
- Shares outstanding
- 68.40M
- Employees
- —
- Next earnings
- —
Other Life Sciences Tools & Services companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Thermo Fisher Scientific Inc.NYSE: TMO | $234.31B | $633.41 | -0.05% |
| Danaher CorporationNYSE: DHR | $151.40B | $216.56 | +0.56% |
| WuXi AppTec Co., Ltd.SHSE: 603259 | $70.42B | CN¥159.25 | -1.09% |
| Samsung Biologics Co.,Ltd.KOSE: A207940 | $51.75B | ₩1,551,000.00 | +0.19% |
| Lonza Group AGSWX: LONN | $50.96B | CHF588.40 | +0.10% |
| Agilent Technologies, Inc.NYSE: A | $43.80B | $157.65 | +1.66% |
| IQVIA Holdings Inc.NYSE: IQV | $43.04B | $263.09 | +0.60% |
| Waters CorporationNYSE: WAT | $40.69B | $423.69 | +2.30% |
Figures last refreshed Aug 18, 2026.